BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 20456946)

  • 1. Meta-analysis: serum vitamin D and breast cancer risk.
    Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
    Eur J Cancer; 2010 Aug; 46(12):2196-205. PubMed ID: 20456946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis: Circulating vitamin D and ovarian cancer risk.
    Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
    Gynecol Oncol; 2011 May; 121(2):369-75. PubMed ID: 21324518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis.
    Yin L; Ordóñez-Mena JM; Chen T; Schöttker B; Arndt V; Brenner H
    Prev Med; 2013 Dec; 57(6):753-64. PubMed ID: 24036014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk.
    Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
    Aliment Pharmacol Ther; 2009 Jul; 30(2):113-25. PubMed ID: 19392870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional risk factors and status of serum 25(OH)D levels in patients with breast cancer: A case control study in India.
    Sofi NY; Jain M; Kapil U; Seenu V; Kamal VK; Pandey RM
    J Steroid Biochem Mol Biol; 2018 Jan; 175():55-59. PubMed ID: 27687737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: Serum vitamin D and colorectal adenoma risk.
    Yin L; Grandi N; Raum E; Haug U; Arndt V; Brenner H
    Prev Med; 2011; 53(1-2):10-6. PubMed ID: 21672549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies.
    Wang D; Vélez de-la-Paz OI; Zhai JX; Liu DW
    Tumour Biol; 2013 Dec; 34(6):3509-17. PubMed ID: 23807676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis.
    Kim Y; Je Y
    Br J Cancer; 2014 May; 110(11):2772-84. PubMed ID: 24714744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
    Feng Y; Cheng G; Wang H; Chen B
    Osteoporos Int; 2017 May; 28(5):1641-1652. PubMed ID: 28220196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.
    Chen GC; Zhang ZL; Wan Z; Wang L; Weber P; Eggersdorfer M; Qin LQ; Zhang W
    Cancer Causes Control; 2015 Dec; 26(12):1719-28. PubMed ID: 26358829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis.
    Mohr SB; Gorham ED; Alcaraz JE; Kane CJ; Macera CA; Parsons JK; Wingard DL; Garland CF
    Anticancer Res; 2011 Sep; 31(9):2939-48. PubMed ID: 21868542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study.
    Sofi NY; Jain M; Kapil U; Seenu V; R L; Yadav CP; Pandey RM; Sareen N
    J Steroid Biochem Mol Biol; 2018 Jan; 175():200-204. PubMed ID: 29137944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
    Garland CF; Gorham ED
    J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.
    Abbas S; Linseisen J; Slanger T; Kropp S; Mutschelknauss EJ; Flesch-Janys D; Chang-Claude J
    Carcinogenesis; 2008 Jan; 29(1):93-9. PubMed ID: 17974532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies.
    Bauer SR; Hankinson SE; Bertone-Johnson ER; Ding EL
    Medicine (Baltimore); 2013 May; 92(3):123-131. PubMed ID: 23625163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
    Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
    Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and breast cancer: A systematic review and meta-analysis of observational studies.
    Hossain S; Beydoun MA; Beydoun HA; Chen X; Zonderman AB; Wood RJ
    Clin Nutr ESPEN; 2019 Apr; 30():170-184. PubMed ID: 30904218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.
    Peppone LJ; Rickles AS; Janelsins MC; Insalaco MR; Skinner KA
    Ann Surg Oncol; 2012 Aug; 19(8):2590-9. PubMed ID: 22446898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association Between Serum Vitamin D Levels and Age-Related Macular Degeneration: A Systematic Meta-Analytic Review.
    Wu W; Weng Y; Guo X; Feng L; Xia H; Jiang Z; Lou J
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2168-77. PubMed ID: 27111565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies.
    Schöttker B; Ball D; Gellert C; Brenner H
    Ageing Res Rev; 2013 Mar; 12(2):708-18. PubMed ID: 22343489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.